New Weight Loss Drugs: Game-Changers in the Pharma Industry

Once known as a consequence of “poor lifestyle decisions and a failure of willpower”, obesity is still on the rise in the US and worldwide with increasing numbers of obesity-related deaths each year. Now widely investigated and admitted as a chronic biological disease, the possibility of finding novel and effective medication for obesity became of great interest in the research community and pharma industry. 

“The new obesity drugs are in a class called incretin mimetics or GLP-1 based drugs, which emulate the effects of  a hormone called glucagon-like peptide 1 that can help people feel full. They can lead to a startling amount of weight loss, up to a fifth of body mass, but have to be taken regularly by injection to avoid regaining pounds.”

SOURCE: https://www.statnews.com/2023/03/05/weight-loss-drugs-changing-obesity-narrative/ 

CREDITS: STAT NEWS